The higher numbers of DCX+ and CR+ granular cells detected at the III–IV AD stages [55,161,162,164] have also been reported in other neuropathologies such as epilepsy, schizophrenia, and Creutzfeld–Jacobs disease [164,168,169,170,171]. Here, CALB2 is linked to Alzheimer disease.